<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00387049</url>
  </required_header>
  <id_info>
    <org_study_id>R01DA018734</org_study_id>
    <secondary_id>R01DA018734</secondary_id>
    <nct_id>NCT00387049</nct_id>
  </id_info>
  <brief_title>Anxiety Sensitivity Program for Smoking Cessation</brief_title>
  <official_title>Anxiety Sensitivity Program for Smoking Cessation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vermont</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Vermont</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop and test a smoking cessation intervention for persons
      who are specifically sensitive to anxiety and anxiety-related bodily sensations.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Smoking status</measure>
    <time_frame>2 weeks post Quit Day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Smoking status</measure>
    <time_frame>4 weeks post Quit Day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Smoking status</measure>
    <time_frame>8 weeks post Quit Day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Smoking status</measure>
    <time_frame>16 weeks post Quit Day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Smoking status</measure>
    <time_frame>24 weeks post Quit Day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Where applicable, length of time from Quit Day to relapse.</measure>
    <time_frame>Determined at conclusion of study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>Anxiety-specific smoking cessation care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard smoking cessation care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Anxiety Sensitivity Program for Smoking Cessation</intervention_name>
    <arm_group_label>Anxiety-specific smoking cessation care</arm_group_label>
    <arm_group_label>Standard smoking cessation care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged between 18 and 65 years old

          2. Not pregnant

          3. Regular smoker averaging 10 or more cigarettes per day for at least one year

          4. Score of 25 or greater on 16-item Anxiety Sensitivity Index

          5. Motivation to Quit score of 7 or greater (using Readiness to Quit Ladder)

          6. Not currently using pharmacotherapy for smoking cessation (e.g., Zyban)

          7. No use of other tobacco products (e.g., chewing tobacco, cigars)

          8. No Axis-I or Axis-II diagnoses other than mood or anxiety disorders (intake interview
             required)

          9. No suicidal or homicidal ideation

         10. No current psychotropic medication use

         11. No evidence of substance abuse or dependence (other than nicotine dependence)

         12. No history of significant medical conditions (cardiovascular, neurological, etc.)

         13. Ability to provide informed, written consent (no evidence of limited mental capacity)

         14. Sufficient command of the English language (able to carry on interview conversation)

         15. Plan to stay in Burlington VT area for at least next 6 months

        Exclusion Criteria:

          1. Not between 18-65 years old

          2. Pregnant or currently trying to become pregnant

          3. Regular smoker for less than one year OR smoke less than 10 cigarettes per day

          4. ASI below cutoff level of 25

          5. Motivation to Quit score of 6 or less (using Readiness to Quit Ladder)

          6. Current or recent use of any pharmacotherapy for smoking cessation (e.g., patch,
             Zyban)

          7. Current use of other tobacco products (e.g., chewing tobacco, cigars)

          8. Axis-I disorders other than anxiety or mood disorders.

          9. Endorsement of suicidality or homicidal ideation.

         10. Any current psychotropic medication use (must have stopped at least 1 month prior).

         11. Any evidence of substance abuse or dependence (other than nicotine dependence)

         12. Any history of significant medical conditions (cardiovascular, neurological, etc.)

         13. Inability to provide informed, written consent (evidence of limited mental capacity)

         14. Insufficient command of the English language (unable to carry on conversation)

         15. Plan to permanently leave Burlington area anytime during the next 6-12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael J. Zvolensky, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Vermont, Department of Psychology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrew R. Yartz, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of Vermont, Department of Psychology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Vermont</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2006</study_first_submitted>
  <study_first_submitted_qc>October 10, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2006</study_first_posted>
  <last_update_submitted>October 21, 2010</last_update_submitted>
  <last_update_submitted_qc>October 21, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 22, 2010</last_update_posted>
  <responsible_party>
    <name_title>Ruth Farrell/Associate Vice President</name_title>
    <organization>University of Vermont</organization>
  </responsible_party>
  <keyword>Anxiety Sensitivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

